Sr. VP of Clinical Development
Fri, Mar 27, 2026
Mar 27
4,256 shares @ $30.04
Decreased holdings by -9.20%
3rd largest trade (out of 20)
Trade made by an officer
Unscheduled trade
0% win rate · -20.2% median edge vs SPY (9 trades, 90-day · small sample)
Price 48% below 200-day moving average
Small Cap stock — insider trades carry more weight